The NeuroPASS™, by CraniUS Therapeutics™, is the world’s first and only drug delivery system designed to bypass the blood-brain barrier using a precise flow rate of medication directly to the brain for the treatment of aggressive brain tumors, Alzheimer’s, and Parkinson’s disease.
Precise Delivery
Designed to deliver consistent microdoses of medication directly to the brain, forming a cloud-like distribution around the tumor or affected area for targeted efficacy.
Reduced Systemic Side Effects
Has the potential to eliminate the debilitating systemic side effects common with traditional treatments, enhancing quality of life for patients.
Invisible, Skull-Implantable Design
Fully skull-implantable design that remains virtually invisible under the skin, with zero visible skull deformity.
Celebrate Our Successes
The future of improved patient and user-focused outcomes
“When evaluating the MRI images from the devices tested by the company, the CraniUS NeuroPASS device is on the way to achieving its goal of convection and that gadolinium was spreading within the white matter of the brain.”
Martin Pomper, MD
“What CraniUS has built, and now tested successfully, in their large animal study is without question a quantum leap forward for our field. It has the immense potential to be a major disruptor in terms of how we, as neurosurgeons, approach and treat brain disease moving forward.”
Henry Brem, MD
“I could not be any prouder of our talented team and the findings of this recent breakthrough study. Being able to show that our patented device is both safe and effective in achieving convection in large animals with similar brains to humans represents a tremendous culmination of hard work and determination by our team.”
Michael Maglin, CEO of CraniUS
